These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 17655808)

  • 1. Leishmania (Leishmania) amazonensis infection and dissemination in mice inoculated with stationary-phase or with purified metacyclic promastigotes.
    Felizardo TC; Toma LS; Borges NB; Lima GM; Abrahamsohn IA
    Parasitology; 2007 Nov; 134(Pt 12):1699-707. PubMed ID: 17655808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 3A1-La monoclonal antibody reveals key features of Leishmania (L) amazonensis metacyclic promastigotes and inhibits procyclics attachment to the sand fly midgut.
    Pinto-da-Silva LH; Fampa P; Soares DC; Oliveira SM; Souto-Padron T; Saraiva EM
    Int J Parasitol; 2005 Jun; 35(7):757-64. PubMed ID: 15885694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological studies of visceralized Leishmania (Leishmania) amazonensis in mice experimentally infected.
    Abreu-Silva AL; Calabrese KS; Cupolilo SM; Cardoso FO; Souza CS; Gonçalves da Costa SC
    Vet Parasitol; 2004 May; 121(3-4):179-87. PubMed ID: 15135858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice.
    Courret N; Lang T; Milon G; Antoine JC
    Int J Parasitol; 2003 Oct; 33(12):1373-83. PubMed ID: 14527520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth cycle-dependent generation of complement-resistant Leishmania promastigotes.
    Franke ED; McGreevy PB; Katz SP; Sacks DL
    J Immunol; 1985 Apr; 134(4):2713-8. PubMed ID: 3973390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of signaling by IL-4 or by IL-4/IL-13 has more attenuating effects on Leishmania amazonensis dorsal skin--than on footpad-infected mice.
    Felizardo TC; Gaspar-Elsas MI; Lima GM; Abrahamsohn IA
    Exp Parasitol; 2012 Jan; 130(1):48-57. PubMed ID: 22019418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease.
    Lira R; Méndez S; Carrera L; Jaffe C; Neva F; Sacks D
    Exp Parasitol; 1998 Jul; 89(3):331-42. PubMed ID: 9676711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hyperbaric oxygen on Leishmania amazonensis promastigotes and amastigotes.
    Arrais-Silva WW; Collhone MC; Ayres DC; de Souza Souto PC; Giorgio S
    Parasitol Int; 2005 Mar; 54(1):1-7. PubMed ID: 15710544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early infection with Leishmania major restrains pathogenic response to Leishmania amazonensis and parasite growth.
    González-Lombana CZ; Santiago HC; Macedo JP; Seixas VA; Russo RC; Tafuri WL; Afonso LC; Vieira LQ
    Acta Trop; 2008 Apr; 106(1):27-38. PubMed ID: 18313021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
    Pereira WK; Lonardoni MV; Grespan R; Caparroz-Assef SM; Cuman RK; Bersani-Amado CA
    J Infect; 2005 Aug; 51(2):157-64. PubMed ID: 16038768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
    Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR
    Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis.
    Calvopina M; Barroso PA; Marco JD; Korenaga M; Cooper PJ; Nonaka S; Hashiguchi Y
    Vaccine; 2006 Jul; 24(27-28):5645-52. PubMed ID: 16621179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wound healing response is a major contributor to the severity of cutaneous leishmaniasis in the ear model of infection.
    Baldwin T; Sakthianandeswaren A; Curtis JM; Kumar B; Smyth GK; Foote SJ; Handman E
    Parasite Immunol; 2007 Oct; 29(10):501-13. PubMed ID: 17883453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathological studies of Leishmania amazonensis infection in resistant and in susceptible mice.
    de Oliveira Cardoso F; de Souza Cda S; Mendes VG; Abreu-Silva AL; Gonçalves da Costa SC; Calabrese KS
    J Infect Dis; 2010 Jun; 201(12):1933-40. PubMed ID: 20462353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune serum from both susceptible and resistant strains of mice increases phagocytosis of Leishmania mexicana amazonensis by macrophages.
    Reis MG; Roters SB; Barral-Netto M
    Acta Trop; 1987 Sep; 44(3):339-42. PubMed ID: 2892370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infections in immunocompetent and immune-deficient mice with promastigotes of a North American isolate of Leishmania infantum.
    Rosypal AC; Zajac AM; Troy GC; Lindsay DS
    Vet Parasitol; 2005 Jun; 130(1-2):19-27. PubMed ID: 15893066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different patterns of disease in two inbred mouse strains infected with a clone of Leishmania mexicana amazonensis.
    Barral-Netto M; Cardoso SA; Barral A
    Acta Trop; 1987 Mar; 44(1):5-11. PubMed ID: 2884839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saliva of laboratory-reared Lutzomyia longipalpis exacerbates Leishmania (Leishmania) amazonensis infection more potently than saliva of wild-caught Lutzomyia longipalpis.
    Laurenti MD; Silveira VM; Secundino NF; Corbett CE; Pimenta PP
    Parasitol Int; 2009 Sep; 58(3):220-6. PubMed ID: 19454323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different patterns of the L-histidine decarboxylase (HDC) gene expression in mice resistant and susceptible to experimental cutaneous leishmaniasis.
    Pós Z; Müller K; Novalphak I; Buzás E; Solbach W; Falus A; Laskay T
    Inflamm Res; 2004 Jan; 53(1):38-43. PubMed ID: 15021979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice.
    Lang T; Goyard S; Lebastard M; Milon G
    Cell Microbiol; 2005 Mar; 7(3):383-92. PubMed ID: 15679841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.